Welcome to LookChem.com Sign In|Join Free
  • or
Roxatidine acetate hydrochloride, also known as ALTAT, is a competitive histamine H2 receptor antagonist that differs significantly in structure from other marketed agents such as cimetidine, ranitidine, and famotidine. It is a white solid that, upon oral absorption, is rapidly converted to its active metabolite, roxatidine. By inhibiting the binding of histamine to H2 receptors, roxatidine reduces both intracellular cAMP concentrations and gastric acid secretion by parietal cells. This makes it useful in the treatment of gastric, duodenal, and anastomotic ulcers, Zollinger-Ellison syndrome, and peptic esophagitis.

93793-83-0

Post Buying Request

93793-83-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

93793-83-0 Usage

Uses

Used in Pharmaceutical Industry:
Roxatidine acetate hydrochloride is used as a histamine H2-receptor antagonist for inhibiting gastric acid secretion. It serves as an antiulcer agent, helping in the treatment of various gastrointestinal conditions such as gastric, duodenal, and anastomotic ulcers, Zollinger-Ellison syndrome, and peptic esophagitis. Its unique structure and mechanism of action make it a valuable addition to the therapeutic options available for these conditions.

Originator

Teikoku Hormone (Japan)

Check Digit Verification of cas no

The CAS Registry Mumber 93793-83-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,3,7,9 and 3 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 93793-83:
(7*9)+(6*3)+(5*7)+(4*9)+(3*3)+(2*8)+(1*3)=180
180 % 10 = 0
So 93793-83-0 is a valid CAS Registry Number.
InChI:InChI=1/C19H28N2O4.ClH/c1-16(22)25-15-19(23)20-9-6-12-24-18-8-5-7-17(13-18)14-21-10-3-2-4-11-21;/h5,7-8,13H,2-4,6,9-12,14-15H2,1H3,(H,20,23);1H

93793-83-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (R0178)  Roxatidine Acetate Hydrochloride  >98.0%(HPLC)(T)

  • 93793-83-0

  • 200mg

  • 550.00CNY

  • Detail
  • TCI America

  • (R0178)  Roxatidine Acetate Hydrochloride  >98.0%(HPLC)(T)

  • 93793-83-0

  • 1g

  • 1,790.00CNY

  • Detail

93793-83-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Roxatidine acetate hydrochloride

1.2 Other means of identification

Product number -
Other names Roxatidine Acetate HCl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:93793-83-0 SDS

93793-83-0Downstream Products

93793-83-0Relevant academic research and scientific papers

Preparation method of high-purity medicinal roxatidine acetate hydrochloride

-

, (2021/02/06)

The invention discloses a preparation method of high-purity medicinal roxatidine acetate hydrochloride, and relates to the field of medicine synthesis. The invention provides the preparation method ofthe medicinal roxatidine acetate hydrochloride which is simple in production process, high in safety coefficient, low in cost, high in yield and extremely low in impurity content. The method comprises the following steps: 1) preparing 3-piperidine methylphenol; (2) preparing N-[3-(3-aminopropoxy)-benzyl] piperidine from the 3-piperidine methylphenol obtained in the step (1); and (3) preparing theroxatidine acetate hydrochloride by adopting the N-[3-(3-aminopropoxy)-benzyl] piperidine in the step (2). The yield of the roxatidine acetate hydrochloride prepared by the method disclosed by the invention can reach 87%, and the purity can reach 99.45%. The method is applied to the field of medicine synthesis.

A preparation method for rosacea acetate hydrochloride

-

, (2021/12/07)

The present invention relates to the field of pharmaceutical preparation technology, in particular to a method for preparing rosatidine acetate hydrochloride. The present invention adopts m-hydroxybenzoic acid as a starting material, a wide range of sources, inexpensive, and it can be prepared by oxidation of m-hydroxytoluene, without involving a toxicity warning structure and nitrosamine impurities; at the same time, in this preparation process only involves a genotoxic warning structure substance, reducing the risk of medication of subsequent drugs.

Preparation method of roxatidine acetate hydrochloride

-

, (2020/05/01)

The invention relates to a preparation method of roxatidine acetate hydrochloride. The preparation method comprises the following steps: step 1, dissolving m-cresol and 3-chloropropylamine hydrochloride into a reaction solvent according to a certain ratio, carrying out a reaction in the presence of an alkali, extracting after the reaction, and concentrating after simple purification to obtain an intermediate 1; 2, dissolving the intermediate 1 and an alkali in a reaction solvent according to a certain ratio, adding acetoxyacetyl chloride in a dropwise manner at a low temperature, and extracting and concentrating after the reaction of the intermediate 1 is finished to obtain an intermediate 2; 3, carrying out a bromination reaction on the intermediate 2 and N-bromosuccinimide, and directlycarrying out water washing extraction to obtain an intermediate 3; 4, carrying out a reaction on the intermediate 3 and excessive piperidine in a solvent, concentrating, extracting with dichloromethane, drying, and further purifying with acetic anhydride to obtain roxatidine acetate; 5, dissolving the intermediate 3 in acetone, adding hydrochloric acid in a dropwise manner to form a salt, filtering, and drying; and 6, mixing with absolute ethyl alcohol, filtering, carrying out cooling crystallization, and drying to obtain the roxatidine acetate hydrochloride.

Novel preparation method of intermediate namely 3-(1-piperidine methyl)phenol of roxatidine acetate hydrochloride

-

, (2018/04/02)

The invention relates to a preparation method of an intermediate namely 3-(1-piperidine methyl)phenol of roxatidine acetate hydrochloride. M-nitrobenzaldehyde is taken as the primary raw material; under the effect of a phase transfer catalyst, m- nitrobenzaldehyde is reduced by metal borohydride to obtain corresponding benzyl alcohol; in the presence of an alkali, benzyl alcohol reacts with organic sulfonyl chloride to generate active organic sulfonate; then in the presence of an alkali, organic sulfonate carries out N-alkylation reactions with piperidine to generate N-substituted piperidine derivatives; reducing the nitro groups of N-substituted piperidine derivatives to obtain corresponding amino compounds; and subjecting the amino compounds to diazotization, hydrolysis, and alkalizationin a sulfuric acid water solution to obtain 3-(1-piperidine methyl)phenol. The problem that the supply of the conventional raw material (m-hydroxyl benzaldehyde) is not enough and the cost is greatlyincreased is solved. The method is simple and safe, the raw materials are cheap and easily available, the reaction yield is high, and the method is very suitable for industrial production of 3-(1-piperidine methyl)phenol.

Preparation method of roxatidine acetate hydrochloride

-

, (2017/07/20)

The invention discloses a preparation method of roxatidine acetate hydrochloride. The preparation method is characterized by adopting m-hydroxybenzaldehyde and piperidine as raw materials for carrying out chemical synthesis under the conditions of microwave radiation and high frequency ultrasonic wave, so that the product yield is improved, the reaction time is shortened, the cost is reduced, the product purity is improved, the total impurities are reduced, and an ideal effect is achieved.

A new synthesis of roxatidine acetate

Tarpanov, Velichko,Vlahov, Radoslav,Penkov, Miho,Krikorian, Dikran,Parushev, Stoyan,Mechkarova, Pepa,Angelova, Nely,Schunack, Walter

, p. 15 - 20 (2007/10/03)

A new four-step synthesis of N-{3-[3-(1-piperidinylmethyl)- phenoxy]propyl}acetoxyacetamide hydrochloride has been performed. The key aralkyl ether was synthesized in high yield under moderate conditions. A suitable scaling up permits a bulky production of the drug in 98.5% purity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 93793-83-0